rs137853001
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_033056.4(PCDH15):c.7C>T(p.Arg3Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000994 in 1,610,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000010 ( 0 hom. )
Consequence
PCDH15
NM_033056.4 stop_gained
NM_033056.4 stop_gained
Scores
3
3
1
Clinical Significance
Conservation
PhyloP100: 6.43
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 248 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-54664256-G-A is Pathogenic according to our data. Variant chr10-54664256-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 4931.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-54664256-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCDH15 | NM_033056.4 | c.7C>T | p.Arg3Ter | stop_gained | 2/33 | ENST00000320301.11 | |
PCDH15 | NM_001384140.1 | c.7C>T | p.Arg3Ter | stop_gained | 2/38 | ENST00000644397.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCDH15 | ENST00000320301.11 | c.7C>T | p.Arg3Ter | stop_gained | 2/33 | 1 | NM_033056.4 | ||
PCDH15 | ENST00000644397.2 | c.7C>T | p.Arg3Ter | stop_gained | 2/38 | NM_001384140.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151878Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
151878
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248430Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134318
GnomAD3 exomes
AF:
AC:
5
AN:
248430
Hom.:
AF XY:
AC XY:
3
AN XY:
134318
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1458478Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 725554
GnomAD4 exome
AF:
AC:
15
AN:
1458478
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
725554
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151878Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74178
GnomAD4 genome
AF:
AC:
1
AN:
151878
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74178
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Usher syndrome type 1F Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 15, 2017 | Variant summary: The PCDH15 c.7C>T (p.Arg3X) variant results in a premature termination codon, predicted to cause a truncated or absent PCDH15 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One truncation downstream of this position have been classified as pathogenic by our laboratory (e.g. c.733C>T, p.Arg245X). One in silico tool predicts a damaging outcome for this variant. This variant was found in 1/108974 control chromosomes at a frequency of 0.0000092, which does not exceed the estimated maximal expected allele frequency of a pathogenic PCDH15 variant (0.0031623). This variant has been reported in multiple studies in patients with USH syndrome, in both homozygotes and heterozygotes (Ahmed_AJHG_2001, Jaijo_BMB_2010, Roux_Invest Ophthalmol Vis Sci_2011), with the UMD-PCDH15 database reporting this variant in 14 patients. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2001 | - - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Dec 15, 2014 | - - |
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 24, 2023 | The p.Arg3Ter variant in PCDH15 has been reported in 4 individuals with Usher syndrome type 1F (PMID: 11487575, 18719945, 27460420, 31541171), segregated with disease in 5 affected relatives from 2 families (PMID: 18719945, 11487575), and has been identified in 0.007% (2/30248) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs137853001). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 4931) and has been interpreted as pathogenic or likely pathogenic by multiple laboratories. Of the 4 affected individuals, 3 of those were homozygotes, which increases the likelihood that the p.Arg3Ter variant is pathogenic (PMID: 11487575, 18719945, 27460420). This nonsense variant leads to a premature termination codon at position 3, which is predicted to lead to a truncated or absent protein. Loss of function of the PCDH15 gene is an established disease mechanism in autosomal recessive Usher syndrome type 1F. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome type 1F. ACMG/AMP Criteria applied: PVS1, PM3, PM2_supporting, PP1_strong (Richards 2015). - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Jul 21, 2020 | - - |
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 23, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 4931). This premature translational stop signal has been observed in individuals with Usher syndrome (PMID: 11487575, 25404053, 27440999, 27460420). This variant is present in population databases (rs137853001, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Arg3*) in the PCDH15 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCDH15 are known to be pathogenic (PMID: 11398101, 11487575, 14570705). - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2016 | - - |
Autosomal recessive nonsyndromic hearing loss 23 Pathogenic:2
Pathogenic, no assertion criteria provided | case-control | Genetic Testing Center for Deafness, Department of Otolaryngology Head & Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital | Feb 26, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 06, 2024 | - - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 07, 2017 | The p.Arg3X variant in PCDH15 has been reported in 10 individuals with Usher syn drome (including 7 homozygous and 1 compound heterozygous) and segregated with d isease in 10 affected relatives from 2 families (Alagramam 2001, Roux 2011, Ahme d 2008, Ahmed 2001, Aparisi 2014, Bonnet 2016, Jaijo 2009, Perreault-Micale 2014 ). This variant has been identified in (1/14512) of Asian chromosomes by the Exo me Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1378530 01); however, this low frequency in the general population is consistent with th e carrier frequency for recessive hearing loss. This nonsense variant leads to a premature termination codon at position 3, which is predicted to lead to a trun cated or absent protein. Loss of PCDH15 function is an established disease mecha nism for Usher syndrome. In summary, this variant meets criteria to be classifie d as pathogenic for autosomal recessive Usher syndrome based on its presence in the homozygous or compound heterozygous state in multiple affected individuals, segregation with disease in multiple affected relatives, extremely low frequency in the general population, and its predicted impact on the protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at